Detalles de la búsqueda
1.
INDUCE-2: A Phase I/II, open-label, two-part study of feladilimab in combination with tremelimumab in patients with advanced solid tumors.
Cancer Immunol Immunother
; 73(3): 44, 2024 Feb 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38349570
2.
A Pilot Study of Sirolimus in Subjects with Cowden Syndrome or Other Syndromes Characterized by Germline Mutations in PTEN.
Oncologist
; 24(12): 1510-e1265, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31350329
3.
Model-based meta-analysis of non-small cell lung cancer with standard of care PD-1 inhibitors and chemotherapy for early development decision making.
CPT Pharmacometrics Syst Pharmacol
; 12(11): 1751-1763, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36642813
4.
Immuno-PET Monitoring of CD8+ T Cell Infiltration Post ICOS Agonist Antibody Treatment Alone and in Combination with PD-1 Blocking Antibody Using a 89Zr Anti-CD8+ Mouse Minibody in EMT6 Syngeneic Tumor Mouse.
Mol Imaging Biol
; 25(3): 528-540, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36266600
5.
Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade.
Cancer Res Commun
; 3(8): 1564-1579, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37593752
6.
Immunodynamics of explanted human tumors for immuno-oncology.
EMBO Mol Med
; 13(1): e12850, 2021 01 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33372722
7.
Phase I, Open-Label, Dose-Escalation Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of GSK2879552 in Relapsed/Refractory SCLC.
J Thorac Oncol
; 14(10): 1828-1838, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31260835
8.
A phase I/II study of pemetrexed with sirolimus in advanced, previously treated non-small cell lung cancer.
Transl Lung Cancer Res
; 8(3): 247-257, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-31367538
9.
PTEN hamartomatous tumor syndromes (PHTS): rare syndromes with great relevance to common cancers and targeted drug development.
Crit Rev Oncol Hematol
; 63(3): 203-14, 2007 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-17643312
10.
Prognostic significance of clinical factors and Akt activation in patients with bronchioloalveolar carcinoma.
Lung Cancer
; 55(1): 115-21, 2007 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17097759
11.
PD-L1 expression in advanced NSCLC: Insights into risk stratification and treatment selection from a systematic literature review.
Lung Cancer
; 112: 200-215, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29191596
12.
Phase I trials of the lysine-specific demethylase 1 inhibitor, GSK2879552, as mono- and combination-therapy in relapsed/refractory acute myeloid leukemia or high-risk myelodysplastic syndromes.
Leuk Lymphoma
; 63(2): 463-467, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34927529
13.
A Phase III Study of Durvalumab (MEDI4736) With or Without Tremelimumab for Previously Treated Patients With Advanced NSCLC: Rationale and Protocol Design of the ARCTIC Study.
Clin Lung Cancer
; 17(3): 232-236.e1, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27265743
14.
A phase I trial of the HIV protease inhibitor nelfinavir in adults with solid tumors.
Oncotarget
; 5(18): 8161-72, 2014 Sep 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-25327558
15.
A phase II, open-label study of ramucirumab in combination with paclitaxel and carboplatin as first-line therapy in patients with stage IIIB/IV non-small-cell lung cancer.
J Thorac Oncol
; 9(10): 1532-9, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25170639
16.
Gefitinib for refractory advanced non-small-cell lung cancer.
Lancet
; 367(9507): 300, 2006 Jan 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-16443034
17.
A phase II study of halichondrin B analog eribulin mesylate (E7389) in patients with advanced non-small cell lung cancer previously treated with a taxane: a California cancer consortium trial.
J Thorac Oncol
; 7(3): 574-8, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22198425
18.
Phase II trial of lapatinib in adult and pediatric patients with neurofibromatosis type 2 and progressive vestibular schwannomas.
Neuro Oncol
; 14(9): 1163-70, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22844108
19.
Rationale for targeting VEGF, FGF, and PDGF for the treatment of NSCLC.
Onco Targets Ther
; 4: 43-58, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21691577
20.
Novel therapies for non-small cell lung cancer.
J Thorac Imaging
; 26(2): 175-85, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21508738